Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		The Effect of High Dose Simvastatine on Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Approved-not yet active				18 and over				Other				2005-004933-16 NCT00281476

Last Modified: 6/2/2006 First Published: 5/23/2006


2.		Phase II Chemoprevention Study of Simvastatin in Women at High Risk of Developing a New Breast Cancer After Undergoing Surgical Resection for Ductal Carcinoma in Situ or Stage I-III Invasive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention				Active				18 and over				NCI				JHOC-J0485 JHOC-SKCCC-J0485, JHOC-04100404, NCT00334542


3.		Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				SMC IRB 2005-08-011 NCT00313859

Last Modified: 8/13/2007 First Published: 7/14/2006


4.		Phase II Pilot Study of Simvastatin on the Pharmacokinetics of Anastrozole in Postmenopausal Women With History of Invasive Breast Cancer or Ductal Carcinoma In Situ or At High Risk for Developing Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention, Treatment				Active				Postmenopausal				NCI				JHOC-J05100 JHOC-SKCCC-J05100, NCT00354640


5.		Gefitinib With or Without Simvastatin in NSCLC

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				NCCCTS-06-177 NCT00452244


6.		Irinotecan/Cisplatin Plus Simvastatin in ED-SCLC

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				NCCCTS-06-176 NCT00452634


7.		Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Approved-not yet active				18 to 80				Other				PSMMSS-01 NCT00503763


8.		Simvastatin in Waldenstrom's Macroglobulinemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				07-175 NCT00575965


9.		Statin Therapy Versus Placebo Prior to Prostatectomy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				CLIN-013-07S VA IRB#1735, SOL-07130-L, NCT00572468

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute